Drug Profile
Atropine micro-formulation - Eyenovia
Alternative Names: ARVN-002; MicroPineLatest Information Update: 26 Jan 2024
Price :
$50
*
At a glance
- Originator Eyenovia
- Developer Arctic Vision; Eyenovia
- Class Alkaloids; Antidotes; Cardiovascular therapies; Eye disorder therapies; Small molecules; Tropanes
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Myopia